BRD4 and ovarian serous adenocarcinoma: Using our collection of patient-derived xenografts (PDXs) representing high-grade serous ovarian cancer (Supplementary Table 1 [40]), we analyzed the correlation between the expression of BRD4 isoforms transcript vs. protein.